Immunological considerations for COVID-19 vaccine strategies

M Jeyanathan, S Afkhami, F Smaill, MS Miller… - Nature Reviews …, 2020 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …

COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations

Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …

Viral targets for vaccines against COVID-19

L Dai, GF Gao - Nature Reviews Immunology, 2021 - nature.com
Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19)
pandemic and to help the return to pre-pandemic normalcy. A great many vaccine …

[HTML][HTML] Current status of COVID-19 vaccine development: focusing on antigen design and clinical trials on later stages

P Lee, CU Kim, SH Seo, DJ Kim - Immune network, 2021 - ncbi.nlm.nih.gov
The global outbreak of coronavirus disease 2019 (COVID-19) is still threatening human
health, economy, and social life worldwide. As a counteraction for this devastating disease …

Will SARS-CoV-2 variants of concern affect the promise of vaccines?

RK Gupta - Nature Reviews Immunology, 2021 - nature.com
Initial optimism regarding the development of COVID-19 vaccines has been tempered by the
emergence of new variants of SARS-CoV-2. Will vaccination be able to contain the …

Recent advances in vaccine and immunotherapy for COVID-19

AA Rabaan, SH Al-Ahmed, R Sah… - Human vaccines & …, 2020 - Taylor & Francis
The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and
hundreds of thousands of deaths. Beyond there being no available antiviral therapy …

A COVID-19 vaccine: big strides come with big challenges

J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …

[HTML][HTML] COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development

R Singh, A Kang, X Luo, M Jeyanathan… - The FASEB …, 2021 - ncbi.nlm.nih.gov
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …

[HTML][HTML] The immunology of SARS-CoV-2 infections and vaccines

L Grigoryan, B Pulendran - Seminars in immunology, 2020 - Elsevier
Abstract SARS-CoV-2, the virus that causes COVID-19, emerged in late 2019, and was
declared a global pandemic on March 11th 2020. With over 50 million cases and 1.2 million …

Vaccines for COVID-19: a systematic review of immunogenicity, current development, and future prospects

Z Zhang, Q Shen, H Chang - Frontiers in immunology, 2022 - frontiersin.org
The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …